Free tool
FAERS Monitor: Norepinephrine Bitartrate In 0.9% Sodium Chloride
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 214313 or its brand name (Norepinephrine Bitartrate In 0.9% Sodium Chloride, Norepinephrine Bitartrate). Reports on generic versions are filed under their own applications.
Reports
2,893
Serious
2,752
95% of reports
Hospitalization
1,305
Death reported
1,086
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective452
- condition aggravated357
- off label use316
- hypotension291
- multiple organ dysfunction syndrome286
- sepsis268
- cardiogenic shock233
- stress229
- general physical health deterioration215
- hyponatraemia201
- renal failure197
- vomiting193
- anaemia188
- death188
- nausea188
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 24 |
| 2005 | 13 |
| 2006 | 48 |
| 2007 | 64 |
| 2008 | 35 |
| 2009 | 61 |
| 2010 | 42 |
| 2011 | 217 |
| 2012 | 86 |
| 2013 | 2 |
| 2014 | 5 |
| 2015 | 4 |
| 2016 | 34 |
| 2017 | 36 |
| 2018 | 61 |
| 2019 | 93 |
| 2020 | 125 |
| 2021 | 183 |
| 2022 | 174 |
| 2023 | 241 |
| 2024 | 226 |
| 2025 | 670 |
| 2026 | 448 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,266 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| cardiogenic shockSignal | 233 | 120.0 | 106.0 | 26,945 |
| multiple organ dysfunction syndromeSignal | 286 | 74.1 | 66.4 | 20,384 |
| hyponatraemiaSignal | 201 | 26.0 | 22.8 | 4,810 |
| stressSignal | 229 | 23.2 | 20.5 | 4,836 |
| sepsisSignal | 268 | 17.5 | 15.6 | 4,167 |
| general physical health deteriorationSignal | 215 | 13.5 | 11.9 | 2,492 |
| renal failureSignal | 197 | 10.8 | 9.4 | 1,750 |
| hypotensionSignal | 291 | 10.6 | 9.5 | 2,530 |
| condition aggravatedSignal | 357 | 8.5 | 7.8 | 2,403 |
| anaemiaSignal | 188 | 7.2 | 6.2 | 1,001 |
| vomitingSignal | 193 | 3.0 | 2.6 | 258 |
| off label useSignal | 316 | 2.6 | 2.4 | 330 |
| drug ineffectiveSignal | 452 | 2.5 | 2.3 | 430 |
| nausea | 188 | 1.7 | 1.5 | 59 |
| death | 188 | 1.6 | 1.4 | 42 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.